Vault-13

VALEANT PHARMACEUTICALS INTL

COM · CUSIP 91911K102

3 institutional holders +0 vs Q1 2020
1,374,7501.4m shares reported held*
$25.1mreported value*
0 new 1 added 0 reduced 0 sold out net bought ≈ $914.1k (+50.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $18.29.

Trends to Q2 2020

Institutional holders

Managers reporting a position, each quarter

0123Q4 19: 2Q1 20: 3Q2 20: 33Q4 19Q1 20Q2 20
Numbers
QuarterHolders
Q4 20192
Q1 20203
Q2 20203

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q1 20: 1 bought or addedQ1 20: 0 cut or sold outQ1 20Q2 20: 1 bought or addedQ2 20: 0 cut or sold outQ2 20
Numbers
QuarterBought or addedCut or sold out
Q1 202010
Q2 202010

Biggest buyers

Bruce & Co., Inc. Added +50,000+50.0k

Biggest sellers

None

Holders, Q2 2020

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Bruce & Co., Inc. 5.41% of their portfolio CHICAGO, IL 1,362,0001.4m $24.9m $24.9m 5.41% Added +50.0k +50,000
2 LeJeune Puetz Investment Counsel LLC 0.12% of their portfolio TRAVERSE CITY, MI 12,75012.8k $233.0k $233.0k 0.12% Unchanged
3 IFP Advisors, Inc 0.00% of their portfolio TAMPA, FL 00 $0 $0 0.00% Unchanged